Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2023 | Understanding the molecular complexity of AML

Pinkal Desai • 10 Jun 2023
EHA 2023
Acute Myeloid Leukemia Leukemia

Pinkal Desai, MD, MPH, Weill Cornell Medical College, New York City, NY, comments on the mutational complexity in patients with acute myeloid leukemia (AML), explaining the importance of large registries that collect molecular data to better understand the impact of mutations and co-mutations on patient outcomes, and thus guide drug development and treatment choices. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

BMS, Servier, Janssen Research

More from Pinkal Desai

2:15
The toxicity of induction therapy in AML
Pinkal Desai • 10 Jun 2023
1:52
Results of Phase I study of MCL-1 inhibition with AZD5991 in R/R hematologic malignancies
Pinkal Desai • 10 Jun 2023
1:24
Phase I study of CD123 NK cell engager SAR443579 in R/R AML, B-ALL or HR-MDS
Pinkal Desai • 10 Jun 2023
3:35
Identifying risk factors for severe COVID-19 in patients with AML, MDS and ALL
Pinkal Desai • 14 Dec 2021

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals